Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 9/20 | 0.62 |
| ▸ | JAK1 | P23458 | 9/20 | 0.62 |
| ▸ | TYK2 | P29597 | 6/20 | 0.47 |
| ▸ | JAK3 | P52333 | 6/20 | 0.47 |
| ▸ | HTR6 | P50406 | 2/20 | 0.43 |
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | DRD4 | P21917 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2224299 | 0.89 | JAK1 (0.50) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2277495 | 0.88 | JAK1 (0.50) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2276637 | 0.88 | JAK1 (0.49) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2277749 | 0.88 | JAK1 (0.49) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2279454 | 0.88 | JAK1 (0.47) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2280027 | 0.88 | JAK1 (0.49) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2280610 | 0.87 | JAK1 (0.47) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL2274899 | 0.87 | JAK1 (0.49) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2278052 | 0.86 | JAK2 (0.48) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2275410 | 0.86 | JAK1 (0.49) | JAK2JAK1TYK2JAK3HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |